{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:27:57Z","timestamp":1771010877651,"version":"3.50.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,9]]},"DOI":"10.1212\/wnl.47.3.705","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:23:00Z","timestamp":1336915380000},"page":"705-711","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":113,"title":["A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease"],"prefix":"10.1212","volume":"47","author":[{"given":"L. J.","family":"Thal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Carta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. R.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. H.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. P.","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W.","family":"Pettegrew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Raskind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H.","family":"Tuszynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. F.","family":"Woolson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"2","volume":"33","year":"1976","unstructured":"Katzman R. The prevalence of malignancy of Alzheimer's disease. Arch Neurol 1976;33:217-218.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_3_2","first-page":"2","volume":"68","year":"1990","unstructured":"Evans DA. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q 1990;68:267-289.","journal-title":"Milbank Q"},{"key":"e_1_3_1_4_2","first-page":"5","volume":"30","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-580.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_5_2","first-page":"4","volume":"27","year":"1990","unstructured":"DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 1990;27:457-464.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_6_2","first-page":"4","volume":"14","year":"1989","unstructured":"Burlina AP, Sershen H, Debler EA, Lajtha A. Uptake of acetyl-L-carnitine in the brain. Neurochem Res 1989;14:489-493.","journal-title":"Neurochem Res"},{"key":"e_1_3_1_7_2","unstructured":"Lehninger AL. Principles of biochemistry. New York: Worth Publishers 1982."},{"key":"e_1_3_1_8_2","unstructured":"Pande SV Noel H Murthy MSR. Characteristics of function of and deficiency of carnitine acylcarnitine translocase. In: Borum PR ed. Clinical aspects of human carnitine deficiency. New York: Pergamon Press 1986:165-180."},{"key":"e_1_3_1_9_2","first-page":"3","volume":"695","year":"1993","unstructured":"Carta A, Calvani M, Bravi D, Bhuachalla SN. Acetyl-L-carnitine and Alzheimer's disease: pharmacological considerations beyond the cholinergic sphere. Ann NY Acad Sci 1993;695:324-326.","journal-title":"Ann NY Acad Sci"},{"key":"e_1_3_1_10_2","first-page":"1","volume":"86","year":"1991","unstructured":"Janiri L, Falcone M, Persico A, Tempesta E. Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo. J Neurotrans 1991;86:135-146.","journal-title":"J Neurotrans"},{"key":"e_1_3_1_11_2","first-page":"5","volume":"15","year":"1990","unstructured":"White HL, Scates PW. Acetyl-L-carnitine as a precursor of acetylcholine. Neurochem Res 1990;15:597-601.","journal-title":"Neurochem Res"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90242-4"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00965820"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4943(92)90002-L"},{"key":"e_1_3_1_15_2","first-page":"2","volume":"43","year":"1988","unstructured":"Fariello RG, Ferraro TN, Golden GT, DeMattei M. Systemic acetyl-L-carnitine elevates nigral levels of glutathione and GABA. Life Sci 1988;43:289-292.","journal-title":"Life Sci"},{"key":"e_1_3_1_16_2","first-page":"4","volume":"11","year":"1990","unstructured":"Markowska AL, Ingram DK, Barnes CA, et al. Acetyl-L-carnitine 1: Effects on mortality, pathology and sensory motor performance in aging rats. Neurobiol Aging 1990;11:491-497.","journal-title":"Neurobiol Aging"},{"key":"e_1_3_1_17_2","first-page":"5","volume":"29","year":"1994","unstructured":"Tangliatela G, Navarra D, Cruciani R, Ramacci MT, Alema GS, Anagelucci L. ALCAR treatment increases nerve growth factor levels in the CNS of aged rats. Exp Gerontol 1994;29:55-66.","journal-title":"Exp Gerontol"},{"key":"e_1_3_1_18_2","first-page":"7","volume":"633","year":"1994","unstructured":"Piovesan P, Pacifici L, Taglialatela G, Ramacci MT, Angelucci L. ALCAR treatment increases choline acetyltransferase activity and NGF levels in the CNS of adult rats following fimbria fornix transection. Brain Res 1994;633:77-82.","journal-title":"Brain Res"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(92)90424-Z"},{"key":"e_1_3_1_20_2","first-page":"1","volume":"215","year":"1982","unstructured":"Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, De Long MR. Alzheimer's disease and single dementia: loss of neurons in the basal forebrain. Science 1982;215:1237-1239.","journal-title":"Science"},{"key":"e_1_3_1_21_2","first-page":"1","volume":"2","year":"1976","unstructured":"Davies P, Maloney AJF. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976;2:1483.","journal-title":"Lancet"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.1.1"},{"key":"e_1_3_1_23_2","first-page":"1","volume":"49","year":"1992","unstructured":"Sano M, Bell K, Cote L, et al. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. Arch Neurol 1992;49:1137-1141.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_24_2","first-page":"6","volume":"11","year":"1990","unstructured":"Rai G, Wright G, Scott L, et al. Double-blind, placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's dementia. Curr Med Res Opin 1990;11:638-647.","journal-title":"Curr Med Res Opin"},{"key":"e_1_3_1_25_2","first-page":"8","volume":"6","year":"1991","unstructured":"Livingston GA, Sax KB, McClenahan Z, et al. Acetyl-L-carnitine in dementia. Int J Geriatr Psychiatry 1991;6:853-860.","journal-title":"Int J Geriatr Psychiatry"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(95)80001-8"},{"key":"e_1_3_1_27_2","first-page":"9","volume":"34","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.","journal-title":"Neurology"},{"key":"e_1_3_1_28_2","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed rev. Washington DC: American Psychiatric Association 1987."},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90017-5"},{"key":"e_1_3_1_30_2","first-page":"4","volume":"7","year":"1980","unstructured":"Rosen WG, Terry RD, Fuld PAA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementia. Ann Neurol 1980;7:486-488.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.1.1"},{"key":"e_1_3_1_32_2","first-page":"5","volume":"140","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for staging of dementia. Br J Psychiatry 1982;140:566-572.","journal-title":"Br J Psychiatry"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/9.4_Part_2.1"},{"key":"e_1_3_1_34_2","unstructured":"Clinical global impressions. In: Guy W ed. ECDEU assessment manual for psychopharmacology. Rev ed. Rockville MD: Department of Health Education and Welfare 1976;218-222 (DHEW publication no (ADM) 76-338.)"},{"key":"e_1_3_1_35_2","first-page":"2","volume":"7","year":"1986","unstructured":"Freiss JL. Analysis of data from multiclinic trials. Control Clin Trials 1986;7:267-275.","journal-title":"Control Clin Trials"},{"key":"e_1_3_1_36_2","first-page":"2","volume":"46","year":"1978","unstructured":"Landis JR, Heyman ER. Average partial association in three-way contingency tables: a review and discussion of alternative tests. Int Statis Rev 1978;46:237-254.","journal-title":"Int Statis Rev"},{"key":"e_1_3_1_37_2","first-page":"M","volume":"47","year":"1992","unstructured":"Freels S, Cohen D, Eisdorfer C, et al. Functional status and clinical findings in patients with Alzheimer's disease. J Gerontol 1992;47:M177-M182.","journal-title":"J Gerontol"},{"key":"e_1_3_1_38_2","first-page":"4","volume":"24","year":"1988","unstructured":"Kramer-Ginsberg E, Mohs RC, Aryan M, et al. Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report. Psychopharmacol Bull 1988;24:458-462.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_1_39_2","first-page":"2","volume":"31","year":"1992","unstructured":"Berg L, Miller JP, Baty J, Rubin EH, Morris JC, Figiel G. Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention. Ann Neurol 1992;31:242-249.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_40_2","first-page":"2","volume":"43","year":"1993","unstructured":"Morris JC, Edland S, Clark C, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993;43:2457-2465.","journal-title":"Neurology"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.1.3"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240103"},{"key":"e_1_3_1_43_2","first-page":"5","volume":"37","year":"1989","unstructured":"Ortof E, Crystal HA. Rate of progression of Alzheimer's disease. J Am Geriatr Soc 1989;37:511-514.","journal-title":"J Am Geriatr Soc"},{"key":"e_1_3_1_44_2","first-page":"3","volume":"39","year":"1991","unstructured":"Burns A, Jacoby R, Levy R. Progression of cognitive impairment of Alzheimer's disease. J Am Geriatr Soc 1991;39:39-45.","journal-title":"J Am Geriatr Soc"},{"key":"e_1_3_1_45_2","unstructured":"Col NF Luckmann RS Bigelow C Fox P Robertson A. Age as a predictor of functional decline in Alzheimer's disease [abstract]. J Am Geriatr Soc 1993;41(suppl A):47."},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1983.04050010021004"},{"key":"e_1_3_1_47_2","first-page":"4","volume":"44","year":"1987","unstructured":"Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iversen LL, Reynolds GP. Age and histopathologic heterogeneity in Alzheimer's disease: evidence of subtypes. Arch Gen Psychiatry 1987;44:412-417.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_1_48_2","first-page":"6","volume":"258","year":"1992","unstructured":"Schellenberg GD, Bird T, Wijsman EM, et al. Genetic linkage for a familial Alzheimer's disease locus on chromosome 14. Science 1992;258:668-671.","journal-title":"Science"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0992-3"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.261.5117.9"},{"key":"e_1_3_1_51_2","first-page":"5","volume":"46","year":"1989","unstructured":"Small GW, Kuhl DE, Reige WH, et al. Cerebral glucose metabolic patterns in Alzheimer's disease: effect of gender and age at dementia onset. Arch Gen Psychiatry 1989;46:527-532.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_1_52_2","first-page":"7","volume":"115","year":"1992","unstructured":"Scheltens PH, Barkhof F, Valk J, et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease: evidence for heterogeneity. Brain 1992;115:735-748.","journal-title":"Brain"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.47.3.705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:15:38Z","timestamp":1711534538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.47.3.705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,9]]}},"alternative-id":["10.1212\/WNL.47.3.705"],"URL":"https:\/\/doi.org\/10.1212\/wnl.47.3.705","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,9]]}}}